-   Training & Support

[Expand/Collapse all sections]Expand all

Rheumatoid arthritis (RA) restriction and item codes

Do not share this attachment externally. See Freedom of Information -
Information Publication Scheme.

[\\INTERNAL.DEPT.LOCAL\Shared\NAT\SERDELEXCEL\WORKPRODIMP\Operation
Blueprint Migration\RDT Release Icons\32w\icon-hidden-attachment.png]PBS
rheumatoid arthritis restriction and item codes

Calculator

[\\INTERNAL.DEPT.LOCAL\Shared\NAT\SERDELEXCEL\WORKPRODIMP\Operation
Blueprint Migration\RDT Release Icons\32w\icon-attachment.png]Next
assessment date calculator

Contact details

PBS Complex Drugs Programs team

Forms

Rheumatoid arthritis – initial authority application (PB109)

Rheumatoid arthritis – continuing authority application (PB111)

Rheumatoid arthritis – change, recommencement or demonstration of
response authority application (PB247)

Rheumatoid arthritis – change of treatment after resolution of critical
shortage of tocilizumab authority application (PB324)

Services Australia website

Arthritis - rheumatoid arthritis

External websites

PBS schedule for Rheumatoid arthritis

Frequently asked questions

For FAQs relevant to all Complex programs, see Processing Complex
Authority Required Listings.

+-----------------------------------+-----------------------------------+
| Item                              | Description                       |
+-----------------------------------+-----------------------------------+
| 1                                 | Question: Does the first          |
|                                   | continuing have to be after 12    |
|                                   | weeks?                            |
|                                   |                                   |
|                                   | Answer: Yes, the patient must     |
|                                   | have at least 12 weeks of therapy |
|                                   | to demonstrate a response to      |
|                                   | treatment. Measure 12 weeks from  |
|                                   | approval date.                    |
+-----------------------------------+-----------------------------------+
| 2                                 | Question: The prescriber provided |
|                                   | both ESR and CRP at baseline but  |
|                                   | is only responding on CRP         |
|                                   | currently – is this ok?           |
|                                   |                                   |
|                                   | Answer: Yes. As long as both      |
|                                   | bloods were qualifying for entry  |
|                                   | at baseline, only responding on   |
|                                   | one of them currently is ok.      |
+-----------------------------------+-----------------------------------+

                                   

-   Services Australia ABN 90 794 605 008 
